Global Drug Elutable Microspheres Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Drug Elutable Microspheres Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 91

Published Date: 30 Apr 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Drug Elutable Microspheres market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug Elutable Microspheres market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Oncology accounting for % of the Drug Elutable Microspheres global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Volume 2ml segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Drug Elutable Microspheres include Terumo, Balton, Boston Scientific, Cook Medical, and Merit Medical, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Drug Elutable Microspheres market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Volume 2ml
Volume 4ml
Others

Market segment by Application can be divided into
Oncology
Vascular Embolism
Others

The key market players for global Drug Elutable Microspheres market are listed below:
Terumo
Balton
Boston Scientific
Cook Medical
Merit Medical
Varian Medical

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Elutable Microspheres product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug Elutable Microspheres, with price, sales, revenue and global market share of Drug Elutable Microspheres from 2019 to 2022.
Chapter 3, the Drug Elutable Microspheres competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Elutable Microspheres breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drug Elutable Microspheres market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Elutable Microspheres.
Chapter 13, 14, and 15, to describe Drug Elutable Microspheres sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Drug Elutable Microspheres Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug Elutable Microspheres Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Volume 2ml
1.2.3 Volume 4ml
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug Elutable Microspheres Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Vascular Embolism
1.3.4 Others
1.4 Global Drug Elutable Microspheres Market Size & Forecast
1.4.1 Global Drug Elutable Microspheres Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drug Elutable Microspheres Sales in Volume (2017-2028)
1.4.3 Global Drug Elutable Microspheres Price (2017-2028)
1.5 Global Drug Elutable Microspheres Production Capacity Analysis
1.5.1 Global Drug Elutable Microspheres Total Production Capacity (2017-2028)
1.5.2 Global Drug Elutable Microspheres Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug Elutable Microspheres Market Drivers
1.6.2 Drug Elutable Microspheres Market Restraints
1.6.3 Drug Elutable Microspheres Trends Analysis

2 Manufacturers Profiles
2.1 Terumo
2.1.1 Terumo Details
2.1.2 Terumo Major Business
2.1.3 Terumo Drug Elutable Microspheres Product and Services
2.1.4 Terumo Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Balton
2.2.1 Balton Details
2.2.2 Balton Major Business
2.2.3 Balton Drug Elutable Microspheres Product and Services
2.2.4 Balton Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boston Scientific
2.3.1 Boston Scientific Details
2.3.2 Boston Scientific Major Business
2.3.3 Boston Scientific Drug Elutable Microspheres Product and Services
2.3.4 Boston Scientific Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cook Medical
2.4.1 Cook Medical Details
2.4.2 Cook Medical Major Business
2.4.3 Cook Medical Drug Elutable Microspheres Product and Services
2.4.4 Cook Medical Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merit Medical
2.5.1 Merit Medical Details
2.5.2 Merit Medical Major Business
2.5.3 Merit Medical Drug Elutable Microspheres Product and Services
2.5.4 Merit Medical Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Varian Medical
2.6.1 Varian Medical Details
2.6.2 Varian Medical Major Business
2.6.3 Varian Medical Drug Elutable Microspheres Product and Services
2.6.4 Varian Medical Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Drug Elutable Microspheres Breakdown Data by Manufacturer
3.1 Global Drug Elutable Microspheres Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drug Elutable Microspheres Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drug Elutable Microspheres
3.4 Market Concentration Rate
3.4.1 Top 3 Drug Elutable Microspheres Manufacturer Market Share in 2021
3.4.2 Top 6 Drug Elutable Microspheres Manufacturer Market Share in 2021
3.5 Global Drug Elutable Microspheres Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drug Elutable Microspheres Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Drug Elutable Microspheres Market Size by Region
4.1.1 Global Drug Elutable Microspheres Sales in Volume by Region (2017-2028)
4.1.2 Global Drug Elutable Microspheres Revenue by Region (2017-2028)
4.2 North America Drug Elutable Microspheres Revenue (2017-2028)
4.3 Europe Drug Elutable Microspheres Revenue (2017-2028)
4.4 Asia-Pacific Drug Elutable Microspheres Revenue (2017-2028)
4.5 South America Drug Elutable Microspheres Revenue (2017-2028)
4.6 Middle East and Africa Drug Elutable Microspheres Revenue (2017-2028)

5 Market Segment by Type
5.1 Global Drug Elutable Microspheres Sales in Volume by Type (2017-2028)
5.2 Global Drug Elutable Microspheres Revenue by Type (2017-2028)
5.3 Global Drug Elutable Microspheres Price by Type (2017-2028)

6 Market Segment by Application
6.1 Global Drug Elutable Microspheres Sales in Volume by Application (2017-2028)
6.2 Global Drug Elutable Microspheres Revenue by Application (2017-2028)
6.3 Global Drug Elutable Microspheres Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
7.1 North America Drug Elutable Microspheres Sales by Type (2017-2028)
7.2 North America Drug Elutable Microspheres Sales by Application (2017-2028)
7.3 North America Drug Elutable Microspheres Market Size by Country
7.3.1 North America Drug Elutable Microspheres Sales in Volume by Country (2017-2028)
7.3.2 North America Drug Elutable Microspheres Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
8.1 Europe Drug Elutable Microspheres Sales by Type (2017-2028)
8.2 Europe Drug Elutable Microspheres Sales by Application (2017-2028)
8.3 Europe Drug Elutable Microspheres Market Size by Country
8.3.1 Europe Drug Elutable Microspheres Sales in Volume by Country (2017-2028)
8.3.2 Europe Drug Elutable Microspheres Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drug Elutable Microspheres Sales by Type (2017-2028)
9.2 Asia-Pacific Drug Elutable Microspheres Sales by Application (2017-2028)
9.3 Asia-Pacific Drug Elutable Microspheres Market Size by Region
9.3.1 Asia-Pacific Drug Elutable Microspheres Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drug Elutable Microspheres Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
10.1 South America Drug Elutable Microspheres Sales by Type (2017-2028)
10.2 South America Drug Elutable Microspheres Sales by Application (2017-2028)
10.3 South America Drug Elutable Microspheres Market Size by Country
10.3.1 South America Drug Elutable Microspheres Sales in Volume by Country (2017-2028)
10.3.2 South America Drug Elutable Microspheres Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drug Elutable Microspheres Sales by Type (2017-2028)
11.2 Middle East & Africa Drug Elutable Microspheres Sales by Application (2017-2028)
11.3 Middle East & Africa Drug Elutable Microspheres Market Size by Country
11.3.1 Middle East & Africa Drug Elutable Microspheres Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drug Elutable Microspheres Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
12.1 Raw Material of Drug Elutable Microspheres and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drug Elutable Microspheres
12.3 Drug Elutable Microspheres Production Process
12.4 Drug Elutable Microspheres Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drug Elutable Microspheres Typical Distributors
13.3 Drug Elutable Microspheres Typical Customers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Drug Elutable Microspheres Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drug Elutable Microspheres Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Terumo Basic Information, Manufacturing Base and Competitors
Table 4. Terumo Major Business
Table 5. Terumo Drug Elutable Microspheres Product and Services
Table 6. Terumo Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Balton Basic Information, Manufacturing Base and Competitors
Table 8. Balton Major Business
Table 9. Balton Drug Elutable Microspheres Product and Services
Table 10. Balton Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 12. Boston Scientific Major Business
Table 13. Boston Scientific Drug Elutable Microspheres Product and Services
Table 14. Boston Scientific Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 16. Cook Medical Major Business
Table 17. Cook Medical Drug Elutable Microspheres Product and Services
Table 18. Cook Medical Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merit Medical Basic Information, Manufacturing Base and Competitors
Table 20. Merit Medical Major Business
Table 21. Merit Medical Drug Elutable Microspheres Product and Services
Table 22. Merit Medical Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Varian Medical Basic Information, Manufacturing Base and Competitors
Table 24. Varian Medical Major Business
Table 25. Varian Medical Drug Elutable Microspheres Product and Services
Table 26. Varian Medical Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Drug Elutable Microspheres Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Drug Elutable Microspheres Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Drug Elutable Microspheres, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Drug Elutable Microspheres Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Drug Elutable Microspheres Production Site of Key Manufacturer
Table 32. Drug Elutable Microspheres New Entrant and Capacity Expansion Plans
Table 33. Drug Elutable Microspheres Mergers & Acquisitions in the Past Five Years
Table 34. Global Drug Elutable Microspheres Sales by Region (2017-2022) & (K Units)
Table 35. Global Drug Elutable Microspheres Sales by Region (2023-2028) & (K Units)
Table 36. Global Drug Elutable Microspheres Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Drug Elutable Microspheres Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 39. Global Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 40. Global Drug Elutable Microspheres Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Drug Elutable Microspheres Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Drug Elutable Microspheres Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Drug Elutable Microspheres Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 45. Global Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 46. Global Drug Elutable Microspheres Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Drug Elutable Microspheres Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Drug Elutable Microspheres Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Drug Elutable Microspheres Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Drug Elutable Microspheres Sales by Country (2017-2022) & (K Units)
Table 51. North America Drug Elutable Microspheres Sales by Country (2023-2028) & (K Units)
Table 52. North America Drug Elutable Microspheres Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Drug Elutable Microspheres Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 55. North America Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 56. North America Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 57. North America Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 58. Europe Drug Elutable Microspheres Sales by Country (2017-2022) & (K Units)
Table 59. Europe Drug Elutable Microspheres Sales by Country (2023-2028) & (K Units)
Table 60. Europe Drug Elutable Microspheres Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Drug Elutable Microspheres Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 63. Europe Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 64. Europe Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 65. Europe Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Drug Elutable Microspheres Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Drug Elutable Microspheres Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Drug Elutable Microspheres Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Drug Elutable Microspheres Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 74. South America Drug Elutable Microspheres Sales by Country (2017-2022) & (K Units)
Table 75. South America Drug Elutable Microspheres Sales by Country (2023-2028) & (K Units)
Table 76. South America Drug Elutable Microspheres Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Drug Elutable Microspheres Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 79. South America Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 80. South America Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 81. South America Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Drug Elutable Microspheres Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Drug Elutable Microspheres Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Drug Elutable Microspheres Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Drug Elutable Microspheres Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 90. Drug Elutable Microspheres Raw Material
Table 91. Key Manufacturers of Drug Elutable Microspheres Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Drug Elutable Microspheres Typical Distributors
Table 95. Drug Elutable Microspheres Typical Customers
List of Figures
Figure 1. Drug Elutable Microspheres Picture
Figure 2. Global Drug Elutable Microspheres Revenue Market Share by Type in 2021
Figure 3. Volume 2ml
Figure 4. Volume 4ml
Figure 5. Others
Figure 6. Global Drug Elutable Microspheres Revenue Market Share by Application in 2021
Figure 7. Oncology
Figure 8. Vascular Embolism
Figure 9. Others
Figure 10. Global Drug Elutable Microspheres Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Drug Elutable Microspheres Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Drug Elutable Microspheres Sales (2017-2028) & (K Units)
Figure 13. Global Drug Elutable Microspheres Price (2017-2028) & (US$/Unit)
Figure 14. Global Drug Elutable Microspheres Production Capacity (2017-2028) & (K Units)
Figure 15. Global Drug Elutable Microspheres Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Drug Elutable Microspheres Market Drivers
Figure 17. Drug Elutable Microspheres Market Restraints
Figure 18. Drug Elutable Microspheres Market Trends
Figure 19. Global Drug Elutable Microspheres Sales Market Share by Manufacturer in 2021
Figure 20. Global Drug Elutable Microspheres Revenue Market Share by Manufacturer in 2021
Figure 21. Drug Elutable Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Drug Elutable Microspheres Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Drug Elutable Microspheres Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Drug Elutable Microspheres Sales Market Share by Region (2017-2028)
Figure 25. Global Drug Elutable Microspheres Revenue Market Share by Region (2017-2028)
Figure 26. North America Drug Elutable Microspheres Revenue (2017-2028) & (USD Million)
Figure 27. Europe Drug Elutable Microspheres Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Drug Elutable Microspheres Revenue (2017-2028) & (USD Million)
Figure 29. South America Drug Elutable Microspheres Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Drug Elutable Microspheres Revenue (2017-2028) & (USD Million)
Figure 31. Global Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 32. Global Drug Elutable Microspheres Revenue Market Share by Type (2017-2028)
Figure 33. Global Drug Elutable Microspheres Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 35. Global Drug Elutable Microspheres Revenue Market Share by Application (2017-2028)
Figure 36. Global Drug Elutable Microspheres Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 38. North America Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 39. North America Drug Elutable Microspheres Sales Market Share by Country (2017-2028)
Figure 40. North America Drug Elutable Microspheres Revenue Market Share by Country (2017-2028)
Figure 41. United States Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 45. Europe Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 46. Europe Drug Elutable Microspheres Sales Market Share by Country (2017-2028)
Figure 47. Europe Drug Elutable Microspheres Revenue Market Share by Country (2017-2028)
Figure 48. Germany Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Drug Elutable Microspheres Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Drug Elutable Microspheres Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Drug Elutable Microspheres Revenue Market Share by Region (2017-2028)
Figure 57. China Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 64. South America Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 65. South America Drug Elutable Microspheres Sales Market Share by Country (2017-2028)
Figure 66. South America Drug Elutable Microspheres Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Drug Elutable Microspheres Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Drug Elutable Microspheres Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Drug Elutable Microspheres in 2021
Figure 78. Manufacturing Process Analysis of Drug Elutable Microspheres
Figure 79. Drug Elutable Microspheres Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Terumo
Balton
Boston Scientific
Cook Medical
Merit Medical
Varian Medical
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Drug Elutable Microspheres Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Drug Elutable Microspheres Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 91

Published Date: 30 Apr 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Drug Elutable Microspheres market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug Elutable Microspheres market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Oncology accounting for % of the Drug Elutable Microspheres global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Volume 2ml segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Drug Elutable Microspheres include Terumo, Balton, Boston Scientific, Cook Medical, and Merit Medical, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Drug Elutable Microspheres market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Volume 2ml
Volume 4ml
Others

Market segment by Application can be divided into
Oncology
Vascular Embolism
Others

The key market players for global Drug Elutable Microspheres market are listed below:
Terumo
Balton
Boston Scientific
Cook Medical
Merit Medical
Varian Medical

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Elutable Microspheres product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug Elutable Microspheres, with price, sales, revenue and global market share of Drug Elutable Microspheres from 2019 to 2022.
Chapter 3, the Drug Elutable Microspheres competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Elutable Microspheres breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drug Elutable Microspheres market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Elutable Microspheres.
Chapter 13, 14, and 15, to describe Drug Elutable Microspheres sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Drug Elutable Microspheres Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug Elutable Microspheres Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Volume 2ml
1.2.3 Volume 4ml
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug Elutable Microspheres Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Vascular Embolism
1.3.4 Others
1.4 Global Drug Elutable Microspheres Market Size & Forecast
1.4.1 Global Drug Elutable Microspheres Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drug Elutable Microspheres Sales in Volume (2017-2028)
1.4.3 Global Drug Elutable Microspheres Price (2017-2028)
1.5 Global Drug Elutable Microspheres Production Capacity Analysis
1.5.1 Global Drug Elutable Microspheres Total Production Capacity (2017-2028)
1.5.2 Global Drug Elutable Microspheres Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug Elutable Microspheres Market Drivers
1.6.2 Drug Elutable Microspheres Market Restraints
1.6.3 Drug Elutable Microspheres Trends Analysis

2 Manufacturers Profiles
2.1 Terumo
2.1.1 Terumo Details
2.1.2 Terumo Major Business
2.1.3 Terumo Drug Elutable Microspheres Product and Services
2.1.4 Terumo Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Balton
2.2.1 Balton Details
2.2.2 Balton Major Business
2.2.3 Balton Drug Elutable Microspheres Product and Services
2.2.4 Balton Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boston Scientific
2.3.1 Boston Scientific Details
2.3.2 Boston Scientific Major Business
2.3.3 Boston Scientific Drug Elutable Microspheres Product and Services
2.3.4 Boston Scientific Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cook Medical
2.4.1 Cook Medical Details
2.4.2 Cook Medical Major Business
2.4.3 Cook Medical Drug Elutable Microspheres Product and Services
2.4.4 Cook Medical Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merit Medical
2.5.1 Merit Medical Details
2.5.2 Merit Medical Major Business
2.5.3 Merit Medical Drug Elutable Microspheres Product and Services
2.5.4 Merit Medical Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Varian Medical
2.6.1 Varian Medical Details
2.6.2 Varian Medical Major Business
2.6.3 Varian Medical Drug Elutable Microspheres Product and Services
2.6.4 Varian Medical Drug Elutable Microspheres Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Drug Elutable Microspheres Breakdown Data by Manufacturer
3.1 Global Drug Elutable Microspheres Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drug Elutable Microspheres Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drug Elutable Microspheres
3.4 Market Concentration Rate
3.4.1 Top 3 Drug Elutable Microspheres Manufacturer Market Share in 2021
3.4.2 Top 6 Drug Elutable Microspheres Manufacturer Market Share in 2021
3.5 Global Drug Elutable Microspheres Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drug Elutable Microspheres Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Drug Elutable Microspheres Market Size by Region
4.1.1 Global Drug Elutable Microspheres Sales in Volume by Region (2017-2028)
4.1.2 Global Drug Elutable Microspheres Revenue by Region (2017-2028)
4.2 North America Drug Elutable Microspheres Revenue (2017-2028)
4.3 Europe Drug Elutable Microspheres Revenue (2017-2028)
4.4 Asia-Pacific Drug Elutable Microspheres Revenue (2017-2028)
4.5 South America Drug Elutable Microspheres Revenue (2017-2028)
4.6 Middle East and Africa Drug Elutable Microspheres Revenue (2017-2028)

5 Market Segment by Type
5.1 Global Drug Elutable Microspheres Sales in Volume by Type (2017-2028)
5.2 Global Drug Elutable Microspheres Revenue by Type (2017-2028)
5.3 Global Drug Elutable Microspheres Price by Type (2017-2028)

6 Market Segment by Application
6.1 Global Drug Elutable Microspheres Sales in Volume by Application (2017-2028)
6.2 Global Drug Elutable Microspheres Revenue by Application (2017-2028)
6.3 Global Drug Elutable Microspheres Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
7.1 North America Drug Elutable Microspheres Sales by Type (2017-2028)
7.2 North America Drug Elutable Microspheres Sales by Application (2017-2028)
7.3 North America Drug Elutable Microspheres Market Size by Country
7.3.1 North America Drug Elutable Microspheres Sales in Volume by Country (2017-2028)
7.3.2 North America Drug Elutable Microspheres Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
8.1 Europe Drug Elutable Microspheres Sales by Type (2017-2028)
8.2 Europe Drug Elutable Microspheres Sales by Application (2017-2028)
8.3 Europe Drug Elutable Microspheres Market Size by Country
8.3.1 Europe Drug Elutable Microspheres Sales in Volume by Country (2017-2028)
8.3.2 Europe Drug Elutable Microspheres Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drug Elutable Microspheres Sales by Type (2017-2028)
9.2 Asia-Pacific Drug Elutable Microspheres Sales by Application (2017-2028)
9.3 Asia-Pacific Drug Elutable Microspheres Market Size by Region
9.3.1 Asia-Pacific Drug Elutable Microspheres Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drug Elutable Microspheres Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
10.1 South America Drug Elutable Microspheres Sales by Type (2017-2028)
10.2 South America Drug Elutable Microspheres Sales by Application (2017-2028)
10.3 South America Drug Elutable Microspheres Market Size by Country
10.3.1 South America Drug Elutable Microspheres Sales in Volume by Country (2017-2028)
10.3.2 South America Drug Elutable Microspheres Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drug Elutable Microspheres Sales by Type (2017-2028)
11.2 Middle East & Africa Drug Elutable Microspheres Sales by Application (2017-2028)
11.3 Middle East & Africa Drug Elutable Microspheres Market Size by Country
11.3.1 Middle East & Africa Drug Elutable Microspheres Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drug Elutable Microspheres Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
12.1 Raw Material of Drug Elutable Microspheres and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drug Elutable Microspheres
12.3 Drug Elutable Microspheres Production Process
12.4 Drug Elutable Microspheres Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drug Elutable Microspheres Typical Distributors
13.3 Drug Elutable Microspheres Typical Customers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Drug Elutable Microspheres Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drug Elutable Microspheres Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Terumo Basic Information, Manufacturing Base and Competitors
Table 4. Terumo Major Business
Table 5. Terumo Drug Elutable Microspheres Product and Services
Table 6. Terumo Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Balton Basic Information, Manufacturing Base and Competitors
Table 8. Balton Major Business
Table 9. Balton Drug Elutable Microspheres Product and Services
Table 10. Balton Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 12. Boston Scientific Major Business
Table 13. Boston Scientific Drug Elutable Microspheres Product and Services
Table 14. Boston Scientific Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 16. Cook Medical Major Business
Table 17. Cook Medical Drug Elutable Microspheres Product and Services
Table 18. Cook Medical Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merit Medical Basic Information, Manufacturing Base and Competitors
Table 20. Merit Medical Major Business
Table 21. Merit Medical Drug Elutable Microspheres Product and Services
Table 22. Merit Medical Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Varian Medical Basic Information, Manufacturing Base and Competitors
Table 24. Varian Medical Major Business
Table 25. Varian Medical Drug Elutable Microspheres Product and Services
Table 26. Varian Medical Drug Elutable Microspheres Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Drug Elutable Microspheres Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Drug Elutable Microspheres Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Drug Elutable Microspheres, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Drug Elutable Microspheres Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Drug Elutable Microspheres Production Site of Key Manufacturer
Table 32. Drug Elutable Microspheres New Entrant and Capacity Expansion Plans
Table 33. Drug Elutable Microspheres Mergers & Acquisitions in the Past Five Years
Table 34. Global Drug Elutable Microspheres Sales by Region (2017-2022) & (K Units)
Table 35. Global Drug Elutable Microspheres Sales by Region (2023-2028) & (K Units)
Table 36. Global Drug Elutable Microspheres Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Drug Elutable Microspheres Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 39. Global Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 40. Global Drug Elutable Microspheres Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Drug Elutable Microspheres Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Drug Elutable Microspheres Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Drug Elutable Microspheres Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 45. Global Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 46. Global Drug Elutable Microspheres Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Drug Elutable Microspheres Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Drug Elutable Microspheres Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Drug Elutable Microspheres Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Drug Elutable Microspheres Sales by Country (2017-2022) & (K Units)
Table 51. North America Drug Elutable Microspheres Sales by Country (2023-2028) & (K Units)
Table 52. North America Drug Elutable Microspheres Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Drug Elutable Microspheres Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 55. North America Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 56. North America Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 57. North America Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 58. Europe Drug Elutable Microspheres Sales by Country (2017-2022) & (K Units)
Table 59. Europe Drug Elutable Microspheres Sales by Country (2023-2028) & (K Units)
Table 60. Europe Drug Elutable Microspheres Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Drug Elutable Microspheres Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 63. Europe Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 64. Europe Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 65. Europe Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Drug Elutable Microspheres Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Drug Elutable Microspheres Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Drug Elutable Microspheres Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Drug Elutable Microspheres Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 74. South America Drug Elutable Microspheres Sales by Country (2017-2022) & (K Units)
Table 75. South America Drug Elutable Microspheres Sales by Country (2023-2028) & (K Units)
Table 76. South America Drug Elutable Microspheres Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Drug Elutable Microspheres Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 79. South America Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 80. South America Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 81. South America Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Drug Elutable Microspheres Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Drug Elutable Microspheres Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Drug Elutable Microspheres Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Drug Elutable Microspheres Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 90. Drug Elutable Microspheres Raw Material
Table 91. Key Manufacturers of Drug Elutable Microspheres Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Drug Elutable Microspheres Typical Distributors
Table 95. Drug Elutable Microspheres Typical Customers
List of Figures
Figure 1. Drug Elutable Microspheres Picture
Figure 2. Global Drug Elutable Microspheres Revenue Market Share by Type in 2021
Figure 3. Volume 2ml
Figure 4. Volume 4ml
Figure 5. Others
Figure 6. Global Drug Elutable Microspheres Revenue Market Share by Application in 2021
Figure 7. Oncology
Figure 8. Vascular Embolism
Figure 9. Others
Figure 10. Global Drug Elutable Microspheres Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Drug Elutable Microspheres Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Drug Elutable Microspheres Sales (2017-2028) & (K Units)
Figure 13. Global Drug Elutable Microspheres Price (2017-2028) & (US$/Unit)
Figure 14. Global Drug Elutable Microspheres Production Capacity (2017-2028) & (K Units)
Figure 15. Global Drug Elutable Microspheres Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Drug Elutable Microspheres Market Drivers
Figure 17. Drug Elutable Microspheres Market Restraints
Figure 18. Drug Elutable Microspheres Market Trends
Figure 19. Global Drug Elutable Microspheres Sales Market Share by Manufacturer in 2021
Figure 20. Global Drug Elutable Microspheres Revenue Market Share by Manufacturer in 2021
Figure 21. Drug Elutable Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Drug Elutable Microspheres Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Drug Elutable Microspheres Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Drug Elutable Microspheres Sales Market Share by Region (2017-2028)
Figure 25. Global Drug Elutable Microspheres Revenue Market Share by Region (2017-2028)
Figure 26. North America Drug Elutable Microspheres Revenue (2017-2028) & (USD Million)
Figure 27. Europe Drug Elutable Microspheres Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Drug Elutable Microspheres Revenue (2017-2028) & (USD Million)
Figure 29. South America Drug Elutable Microspheres Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Drug Elutable Microspheres Revenue (2017-2028) & (USD Million)
Figure 31. Global Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 32. Global Drug Elutable Microspheres Revenue Market Share by Type (2017-2028)
Figure 33. Global Drug Elutable Microspheres Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 35. Global Drug Elutable Microspheres Revenue Market Share by Application (2017-2028)
Figure 36. Global Drug Elutable Microspheres Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 38. North America Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 39. North America Drug Elutable Microspheres Sales Market Share by Country (2017-2028)
Figure 40. North America Drug Elutable Microspheres Revenue Market Share by Country (2017-2028)
Figure 41. United States Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 45. Europe Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 46. Europe Drug Elutable Microspheres Sales Market Share by Country (2017-2028)
Figure 47. Europe Drug Elutable Microspheres Revenue Market Share by Country (2017-2028)
Figure 48. Germany Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Drug Elutable Microspheres Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Drug Elutable Microspheres Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Drug Elutable Microspheres Revenue Market Share by Region (2017-2028)
Figure 57. China Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 64. South America Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 65. South America Drug Elutable Microspheres Sales Market Share by Country (2017-2028)
Figure 66. South America Drug Elutable Microspheres Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Drug Elutable Microspheres Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Drug Elutable Microspheres Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Drug Elutable Microspheres Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Drug Elutable Microspheres in 2021
Figure 78. Manufacturing Process Analysis of Drug Elutable Microspheres
Figure 79. Drug Elutable Microspheres Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Terumo
Balton
Boston Scientific
Cook Medical
Merit Medical
Varian Medical
jiaGou

Add To Cart

gouMai

Buy Now